Search

Search Results

• Chronic Lymphocytic Leukemia: A Genomic Landscape and Cellular Signal Pathways

  M.A. Mikhaleva, Evgenii Olegovich Kunevich, A.Yu. Kuvshinov, S.V. Voloshin

  21-37

  01.01.2025

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Significance of the Expression of pAKT1 and pSyk Activation Proteins in Diffuse Large B-Cell Lymphoma

  Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, S.V. Samarina, I.V. Paramonov

  140-147

  01.04.2022

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia

  Yuliya Nikolaevna Dubinina, V.O. Sarzhevskii, V.Ya. Melnichenko

  461-467

  01.10.2019

• Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

  Maiya Valer’evna Firsova, L.P. Mendeleeva, A.M. Kovrigina, M.V. Solov’ev, N.L. Deineko, M.Yu. Drokov, V.G. Savchenko

  377-384

  01.10.2019

• Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma

  S.M. Rastorguev, D.A. Koroleva, E.S. Boulygina, S.V. Tsygankova, N.G. Goncharov, O.S. Naraikin, N.G. Gabeeva, E.E. Zvonkov, A.V. Nedoluzhko

  95-100

  01.01.2019

• Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders

  E.A. Penskaya, Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, L.G. Gorenkova, L.V. Plastinina, V.V. Tikhonova, Yu.P. Finashutina, N.A. Lyzhko, N.N. Kasatkina, L.A. Kesaeva, O.N. Solopova, A.V. Misyurin

  73-78

  01.01.2019

• Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

  Aleksandr Sergeevich Luchinin, S.V. Semochkin, N.V. Minaeva, N.M. Pozdeev, I.V. Paramonov

  175-181

  01.04.2018

• Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevitch, E.A. Demina, N.B. Senyuta, I.V. Botezatu, K.V. Smirnova, T.E. Dushen’kina, D.M. Maksimovich, U.V. Paramonova, I.S. Monin, A.V. Lichtenshtein

  160-166

  01.04.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

  L.L. Girshova, Irina Garmaevna Budaeva, E.G. Ovsyannikova, S.O. Kuzin, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskii

  485-493

  01.10.2017

• Cytogenetic and Molecular Genetic Prognostic Factors of Acute Lymphoblastic Leukemias

  Andrei Vital’evich Misyurin

  317-323

  01.07.2017

• Cytogenetic and Molecular Genetic Prognostic Factors of Acute Myeloid Leukemia

  Andrei Vital’evich Misyurin

  227-234

  01.04.2017

• Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera

  Dzhariyat Ismailovna Shikhbabaeva, L.B. Polushkina, V.A. Shuvaev, I.S. Martynkevich, S.I. Kapustin, T.B. Zamotina, M.S. Fominykh, V.U. Udal’eva, I.I. Zotova, V.M. Shmeleva, O.A. Smirnova, S.V. Voloshin, S.S. Bessmel’tsev, A.V. Chechetkin, K.M. Abdulkadyrov

  85-92

  01.01.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children

  Elena Vol’fovna Fleishman, O.I. Sokova, A.V. Popa, G.A. Tsaur, L.N. Konstantinova, O.M. Plekhanova, M.V. Strigaleva, E.S. Nokhrina, V.S. Nemirovchenko, O.R. Arakaev

  446-455

  01.10.2016

• Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

  Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, V.Ya. Mel’nichenko

  465-473

  01.10.2016

• Clinical Significance of Immunophenotyping of Bone Marrow Cells in Multiple Myeloma

  Oksana Yur’evna Yakimovich, O.M. Votyakova, N.V. Lyubimova, N.N. Tupitsyn

  296-301

  01.07.2016

• Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)

  Andrei Sergeevich Levashov, T.T. Valiev, A.M. Kovrigina, A.V. Popa, G.L. Mentkevich

  199-207

  01.04.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Complex Karyotype in Pediatric Acute Myeloid Leukemia

  Elena Vol’fovna Fleischman, O.I. Sokova, A.V. Popa, I.I. Kalinina, L.N. Konstantinova

  151-160

  01.04.2015

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013